Accumulating Preclinical Evidence Turmeric Inhibits SARS-CoV-2—German Study

German infectious disease, virologist, and microbiologist research specialists led by Albert Krawczyk, Ph.D. from University of Essen’s West German Centre of Infectious Diseases as well as University Hospital Essen’s Institute for Virology and team sought to investigate if herbal medicines with known antiviral properties had any meaningful impact on SARS-CoV-2, the virus behind COVID-19. One such target is turmeric root, used by Asian societies for cooking as well as in herbal medicine for thousands of years. It turns out the herb’s bioactive ingredient called curcumin exhibits a broad-spectrum antimicrobial activity according to the German scientists. In a recent study, the team tested the antiviral activities of “aqueous turmeric root extract, the dissolved content of a curcumin-containing nutritional supplement capsule, and pure curcumin against SARS-CoV-2.” The author’s recap that in a series of the early state, preclinical lab experiments using cell cultures (VERO E6 and human Calu-3) supernatants, turmeric root extract, dissolved turmeric capsule content, as well as pure curcumin successfully neutralize the novel coronavirus SARS-CoV-2 at subtoxic levels....

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee